Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHSBC Holdings Regulatory News (HSBA)

Share Price Information for HSBC Holdings (HSBA)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 686.50
Bid: 660.00
Ask: 690.00
Change: 0.00 (0.00%)
Spread: 30.00 (4.545%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 686.50
HSBA Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Annual Financial Report - 46 of 56

18 Mar 2016 17:00

RNS Number : 6384S
HSBC Holdings PLC
18 March 2016
 

Consolidated income statement

for the year ended 31 December 2015

2015

2014

2013

Notes

$m

$m

$m

Interest income

47,189

50,955

51,192

Interest expense

(14,658)

(16,250)

(15,653)

Net interest income

32,531

34,705

35,539

Fee income

18,016

19,545

19,973

Fee expense

(3,311)

(3,588)

(3,539)

Net fee income

14,705

15,957

16,434

Trading income excluding net interest income

6,948

4,853

6,643

Net interest income on trading activities

1,775

1,907

2,047

Net trading income

8,723

6,760

8,690

Changes in fair value of long-term debt issued and related derivatives

863

508

(1,228)

Net income from other financial instruments designated at fair value

669

1,965

1,996

Net income from financial instruments designated at fair value

2

1,532

2,473

768

Gains less losses from financial investments

2,068

1,335

2,012

Dividend income

123

311

322

Net insurance premium income

3

10,355

11,921

11,940

Other operating income

1,055

1,131

2,632

Total operating income

71,092

74,593

78,337

Net insurance claims and benefits paid and movement in liabilities to policyholders

4

(11,292)

(13,345)

(13,692)

Net operating income before loan impairment charges and other credit risk provisions

59,800

61,248

64,645

Loan impairment charges and other credit risk provisions

5

(3,721)

(3,851)

(5,849)

Net operating income

56,079

57,397

58,796

Employee compensation and benefits

6

(19,900)

(20,366)

(19,196)

General and administrative expenses

(17,662)

(18,565)

(17,065)

Depreciation and impairment of property, plant and equipment

(1,269)

(1,382)

(1,364)

Amortisation and impairment of intangible assets

20

(937)

(936)

(931)

Total operating expenses

(39,768)

(41,249)

(38,556)

Operating profit

5

16,311

16,148

20,240

Share of profit in associates and joint ventures

19

2,556

2,532

2,325

Profit before tax

18,867

18,680

22,565

Tax expense

8

(3,771)

(3,975)

(4,765)

Profit for the year

15,096

14,705

17,800

Profit attributable to shareholders of the parent company

13,522

13,688

16,204

Profit attributable to non-controlling interests

1,574

1,017

1,596

$

$

$

Basic earnings per ordinary share

10

0.65

0.69

0.84

Diluted earnings per ordinary share

10

0.64

0.69

0.84

The accompanying notes on pages 347 to 469 form an integral part of these financial statements1.

For footnote, see page 346.

 

Consolidated statement of comprehensive income

for the year ended 31 December 2015

2015

2014

2013

$m

$m

$m

Profit for the year

15,096

14,705

17,800

Other comprehensive income/(expense)

Items that will be reclassified subsequently to profit or loss when specificconditions are met:

Available-for-sale investments

(3,072)

2,972

(1,718)

- fair value gains/(losses)

(1,231)

4,794

(1,787)

- fair value gains reclassified to the income statement

(2,437)

(1,672)

(1,277)

- amounts reclassified to the income statement in respect of impairment losses

127

374

286

- income taxes

469

(524)

1,060

Cash flow hedges

(24)

188

(128)

- fair value gains

704

1,512

776

- fair value gains reclassified to the income statement

(705)

(1,244)

(894)

- income taxes

(23)

(80)

(10)

Share of other comprehensive income/(expense) of associates andjoint ventures

(9)

80

(71)

- share for the year

(9)

78

(35)

- reclassified to income statement on disposal

-

2

(36)

Exchange differences

(10,945)

(8,903)

(1,372)

- foreign exchange gains reclassified to income statement on disposal of aforeign operation

-

(21)

(290)

- other exchange differences

(11,112)

(8,917)

(1,154)

- Income tax attributable to exchange differences

167

35

72

Items that will not be reclassified subsequently to profit or loss:

Remeasurement of defined benefit asset/liability

101

1,985

(458)

- before income taxes

130

2,419

(601)

- income taxes

(29)

(434)

143

Other comprehensive income for the year, net of tax

(13,949)

(3,678)

(3,747)

Total comprehensive income for the year

1,147

11,027

14,053

Attributable to:

- shareholders of the parent company

460

9,245

12,644

- non-controlling interests

687

1,782

1,409

Total comprehensive income for the year

1,147

11,027

14,053

The accompanying notes on pages 347 to 469 form an integral part of these financial statements1.

For footnote, see page 346.

 

Consolidated balance sheet

at 31 December 2015

2015

2014

Notes

$m

$m

Assets

Cash and balances at central banks

98,934

129,957

Items in the course of collection from other banks

5,768

4,927

Hong Kong Government certificates of indebtedness

28,410

27,674

Trading assets

12

224,837

304,193

Financial assets designated at fair value

15

23,852

29,037

Derivatives

16

288,476

345,008

Loans and advances to banks

90,401

112,149

Loans and advances to customers

924,454

974,660

Reverse repurchase agreements - non-trading

146,255

161,713

Financial investments

17

428,955

415,467

Assets held for sale

23

43,900

7,647

Prepayments, accrued income and other assets

22

54,398

 67,529

Current tax assets

1,221

1,309

Interests in associates and joint ventures

19

19,139

18,181

Goodwill and intangible assets

20

24,605

27,577

Deferred tax assets

8

6,051

7,111

Total assets at 31 December

2,409,656

2,634,139

Liabilities and equity

Liabilities

Hong Kong currency notes in circulation

28,410

27,674

Deposits by banks

54,371

77,426

Customer accounts

1,289,586

1,350,642

Repurchase agreements - non-trading

80,400

107,432

Items in the course of transmission to other banks

5,638

5,990

Trading liabilities

24

141,614

190,572

Financial liabilities designated at fair value

25

66,408

76,153

Derivatives

16

281,071

340,669

Debt securities in issue

26

88,949

95,947

Liabilities of disposal groups held for sale

23

36,840

6,934

Accruals, deferred income and other liabilities

27

38,116

 46,462

Current tax liabilities

783

1,213

Liabilities under insurance contracts

28

69,938

73,861

Provisions

29

5,552

4,998

Deferred tax liabilities

8

1,760

1,524

Subordinated liabilities

30

22,702

26,664

Total liabilities at 31 December

2,212,138

2,434,161

Equity

Called up share capital

35

9,842

9,609

Share premium account

12,421

11,918

Other equity instruments

15,112

11,532

Other reserves

7,109

20,244

Retained earnings

143,976

137,144

Total shareholders' equity

188,460

190,447

Non-controlling interests

34

9,058

9,531

Total equity at 31 December

197,518

199,978

Total liabilities and equity at 31 December

2,409,656

2,634,139

The accompanying notes on pages 347 to 469 form an integral part of these financial statements1.

For footnote, see page 346.

Douglas Flint, Group Chairman Iain Mackay, Group Finance Director

Consolidated statement of cash flows

for the year ended 31 December 2015

2015

2014

2013

Notes

$m

$m

$m

Cash flows from operating activities

Profit before tax

18,867

18,680

22,565

Adjustments for:

- net gain from investing activities

(1,935)

(1,928)

(1,458)

- share of profits in associates and joint ventures

(2,556)

(2,532)

(2,325)

- (gain)/loss on disposal of associates, joint ventures, subsidiaries and businesses

-

9

(1,173)

- other non-cash items included in profit before tax

36

10,765

11,262

11,995

- change in operating assets

36

65,828

25,877

(148,899)

- change in operating liabilities

36

(106,762)

(93,814)

164,757

- elimination of exchange differences3

18,308

24,571

4,479

- dividends received from associates

879

757

694

- contributions paid to defined benefit plans

(664)

(681)

(962)

- tax paid

(3,852)

(3,573)

(4,696)

Net cash generated from/(used in) operating activities

(1,122)

(21,372)

44,977

Cash flows from investing activities

Purchase of financial investments

(438,376)

(384,199)

(363,979)

Proceeds from the sale and maturity of financial investments

399,636

382,837

342,539

Purchase of property, plant and equipment

(1,352)

(1,477)

(1,952)

Proceeds from the sale of property, plant and equipment

103

88

441

Net cash inflow/(outflow) from disposal of customer and loan portfolios

2,023

(1,035)

6,518

Net investment in intangible assets

(954)

(903)

(834)

Proceeds from disposal of Ping An

-

-

7,413

Net cash inflow/(outflow) from disposal of other subsidiaries, businesses,associates and joint ventures

8

(272)

3,269

Net cash generated from/(used in) investing activities

(38,912)

(4,961)

(6,585)

Cash flows from financing activities

Issue of ordinary share capital

147

267

297

Net sales/(purchases) of own shares for market-making and investment purposes

331

(96)

(32)

Issue of other equity instruments

3,580

5,681

-

Redemption of preference shares and other equity instruments

(463)

(234)

-

Subordinated loan capital issued

3,180

3,500

1,989

Subordinated loan capital repaid

(2,157)

(3,163)

(1,662)

Dividends paid to shareholders of the parent company

(6,548)

(6,611)

(6,414)

Dividends paid to non-controlling interests

(697)

(639)

(586)

Dividends paid to holders of other equity instruments

(950)

(573)

(573)

Net cash used in financing activities

(3,577)

(1,868)

(6,981)

Net increase/(decrease) in cash and cash equivalents

(43,611)

(28,201)

31,411

Cash and cash equivalents at 1 January

301,301

346,281

315,308

Exchange differences in respect of cash and cash equivalents

(13,827)

(16,779)

(438)

Cash and cash equivalents at 31 December

36

243,863

301,301

346,281

The accompanying notes on pages 347 to 469 form an integral part of these financial statements1.

For footnotes, see page 346.

 

Consolidated statement of changes in equity

for the year ended 31 December 2015

Other reserves

Called up share capital

Share

premium

Other equity instru-

ments2

Retained

Earnings4,6

Available- for-sale fair value

reserve5

Cash flow

hedging

reserve5

Foreign

exchange

reserve5

Merger

reserve6,7

Total share- holders' equity

Non- controlling

interests

Total equity

$m

$m

$m

$m

$m

$m

$m

$m

$m

$m

$m

At 1 January 2015

9,609

11,918

11,532

137,144

2,143

58

(9,265)

27,308

190,447

9,531

199,978

Profit for the year

-

-

-

13,522

-

-

-

-

13,522

1,574

15,096

Other comprehensive income (net of tax)

-

-

-

73

(2,332)

(24)

(10,779)

-

(13,062)

(887)

(13,949)

- available-for-sale investments

-

-

-

-

(2,332)

-

-

-

(2,332)

(740)

(3,072)

- cash flow hedges

-

-

-

-

-

(24)

-

-

(24)

-

(24)

- remeasurement of defined benefit asset/liability

-

-

-

82

-

-

-

-

82

19

101

- share of other comprehensive income of associates and joint ventures

-

-

-

(9)

-

-

-

-

(9)

-

(9)

- exchange differences

-

-

-

-

-

-

(10,779)

-

(10,779)

(166)

(10,945)

Total comprehensive income for the year

-

-

-

13,595

(2,332)

(24)

(10,779)

-

460

687

1,147

45

Shares issued under employee remuneration and share plans

45

691

-

(589)

-

-

-

-

147

-

147

Shares issued in lieu of dividends and amounts arising thereon

188

(188)

-

3,162

-

-

-

-

3,162

-

3,162

Capital securities issued

-

-

3,580

-

-

-

-

-

3,580

-

3,580

Dividends to shareholders

-

-

-

(10,660)

-

-

-

-

(10,660)

(697)

(11,357)

Cost of share-based payment arrangements

-

-

-

757

-

-

-

-

757

-

757

Other movements

-

-

-

567

-

-

-

-

567

(463)

104

At 31 December 2015

9,842

12,421

15,112

143,976

(189)

34

(20,044)

27,308

188,460

9,058

197,518

At 1 January 2014

9,415

11,135

5,851

128,728

97

(121)

(542)

27,308

181,871

8,588

190,459

Profit for the year

13,688

13,688

1,017

14,705

Other comprehensive income (net of tax)

2,066

2,025

189

(8,723)

(4,443)

765

(3,678)

- available-for-sale investments

2,025

2,025

947

2,972

- cash flow hedges

189

189

(1)

188

- remeasurement of defined benefit asset/liability

1,986

1,986

(1)

1,985

- share of other comprehensive income of associates and joint ventures

80

80

80

- exchange differences

(8,723)

(8,723)

(180)

(8,903)

Total comprehensive income for the year

15,754

2,025

189

(8,723)

9,245

1,782

11,027

Shares issued under employee remuneration and share plans

60

917

(710)

267

267

Shares issued in lieu of dividends and amounts arising thereon

134

(134)

2,709

2,709

2,709

Capital securities issued

5,681

5,681

5,681

Dividends to shareholders

(9,893)

(9,893)

(712)

(10,605)

Cost of share-based payment arrangements

732

732

732

Other movements

(176)

21

(10)

(165)

(127)

(292)

At 31 December 2014

9,609

11,918

11,532

137,144

2,143

58

(9,265)

27,308

190,447

9,531

199,978

 

Consolidated statement of changes in equity (continued)

Other reserves

Called up share capital

Share

premium

Other equity instru-

ments

Retained

Earnings4,6

Available- for-sale fair value reserve

Cash flow

hedging

reserve

Foreign exchange reserve

Merger

reserve6,7

Total share- holders' equity

Non- controlling

interests

Total equity

$m

$m

$m

$m

$m

$m

$m

$m

$m

$m

$m

At 1 January 2013

9,238

10,084

5,851

120,347

1,649

13

752

27,308

175,242

7,887

183,129

Profit for the year

16,204

16,204

1,596

17,800

Other comprehensive income (net of tax)

(561)

(1,577)

(128)

(1,294)

(3,560)

(187)

(3,747)

- available-for-sale investments

(1,577)

(1,577)

(141)

(1,718)

- cash flow hedges

(128)

(128)

(128)

- remeasurement of defined benefit asset/liability

(490)

(490)

32

(458)

- share of other comprehensive income of associates and joint ventures

(71)

(71)

(71)

- exchange differences

(1,294)

(1,294)

(78)

(1,372)

Total comprehensive income for the year

15,643

(1,577)

(128)

(1,294)

12,644

1,409

14,053

Shares issued under employee remuneration and share plans

60

1,168

(931)

297

297

Shares issued in lieu of dividends and amounts arising thereon

117

(117)

2,523

2,523

2,523

Dividends to shareholders

(9,510)

(9,510)

(718)

(10,228)

Cost of share-based payment arrangements

630

630

630

Other movements

26

25

(6)

45

10

55

At 31 December 2013

9,415

11,135

5,851

128,728

97

(121)

(542)

27,308

181,871

8,588

190,459

The accompanying notes on pages 347 to 469 form an integral part of these financial statements1.

For footnotes, see page 346.

HSBC Holdings balance sheet

at 31 December 2015

2015

2014

Notes

$m

$m

Assets

Cash at bank and in hand:

- balances with HSBC undertakings

242

249

Derivatives

16

2,467

2,771

Loans and advances to HSBC undertakings

44,350

43,910

Financial investments in HSBC undertakings

4,285

4,073

Prepayments, accrued income and other assets

265

125

Current tax assets

723

472

Investments in subsidiaries

21

97,770

96,264

Intangible assets

75

-

Deferred tax assets

17

-

Total assets at 31 December

150,194

147,864

Liabilities and equity

Liabilities

Amounts owed to HSBC undertakings

2,152

2,892

Financial liabilities designated at fair value

25

19,853

18,679

Derivatives

16

2,278

1,169

Debt securities in issue

26

960

1,009

Accruals, deferred income and other liabilities

1,642

1,398

Deferred tax liabilities

-

17

Subordinated liabilities

30

15,895

17,255

Total liabilities

42,780

42,419

Equity

Called up share capital

35

9,842

9,609

Share premium account

12,421

11,918

Other equity instruments

15,020

11,476

Other reserves

37,907

37,456

Retained earnings

32,224

34,986

Total equity

107,414

105,445

Total liabilities and equity at 31 December

150,194

147,864

The accompanying notes on pages 347 to 469 form an integral part of these financial statements1.

For footnote, see page 346.

Douglas Flint Iain Mackay 

Group Chairman Group Finance Director

 

HSBC Holdings statement of cash flows

for the year ended 31 December 2015

2015

2014

Notes

$m

$m

Cash flows from operating activities

Profit before tax

4,282

6,228

Adjustments for:

- non-cash items included in profit before tax

36

114

52

- change in operating assets

36

543

1,854

- change in operating liabilities

36

(2,342)

(9,914)

- tax received

470

133

Net cash generated from/(used in) operating activities

3,067

(1,647)

Cash flows from investing activities

Net cash outflow from acquisition of or increase in stake of subsidiaries

(2,118)

(1,603)

Repayment of capital from subsidiaries

790

3,505

Net investment in intangible assets

(79)

-

Net cash generated from/(used in) investing activities

(1,407)

1,902

Cash flows from financing activities

Issue of ordinary share capital

678

924

Issue of other equity instruments

3,538

5,635

Subordinated loan capital issued

3,180

3,500

Subordinated loan capital repaid

(1,565)

(1,654)

Debt securities repaid

-

(1,634)

Dividends paid on ordinary shares

(6,548)

(6,611)

Dividends paid to holders of other equity instruments

(950)

(573)

Net cash used in financing activities

(1,667)

(413)

Net decrease in cash and cash equivalents

(7)

(158)

Cash and cash equivalents at 1 January

249

407

Cash and cash equivalents at 31 December

36

242

249

The accompanying notes on pages 347 to 469 form an integral part of these financial statements1.

For footnote, see page 346.

 

HSBC Holdings statement of changes in equity

for the year ended 31 December 2015

Other reserves

Called up share capital

Share

premium

Other equity instru-

ments

Retained

earnings8

Available- for-sale fair value reserve

Other

paid-in

capital9

Merger and other

reserves7

Total share- holders' equity

$m

$m

$m

$m

$m

$m

$m

$m

At 1 January 2015

9,609

11,918

11,476

34,986

240

2,089

35,127

105,445

Profit for the year

-

-

-

4,853

-

-

-

4,853

Other comprehensive income (net of tax)

-

-

-

-

(57)

-

-

(57)

- available-for-sale investments

-

-

-

-

(77)

-

-

(77)

- income tax

-

-

-

-

20

-

-

20

Total comprehensive income for the year

-

-

-

4,853

(57)

-

-

4,796

Shares issued under employee share plans

45

691

-

(59)

-

-

-

677

Shares issued in lieu of dividends and amounts arising thereon

188

(188)

-

3,162

-

-

-

3,162

Capital securities issued

-

-

3,544

-

-

-

-

3,544

Dividends to shareholders

-

-

-

(10,660)

-

-

-

(10,660)

Tax credit on distributions

-

-

-

157

-

-

-

157

Own shares adjustment

-

-

-

180

-

-

-

180

Exercise and lapse of share options

-

-

-

(508)

-

508

-

-

Cost of share-based payment arrangements

-

-

-

86

-

-

-

86

Income taxes on share-based payments

-

-

-

1

-

-

-

1

Equity investments granted to employees of subsidiaries under employee share plans

-

-

-

26

-

-

-

26

At 31 December 2015

9,842

12,421

15,020

32,224

183

2,597

35,127

107,414

At 1 January 2014

9,415

11,135

5,828

35,406

124

2,052

35,127

99,087

Profit for the year

-

-

-

6,527

-

-

-

6,527

Other comprehensive income (net of tax)

-

-

-

-

116

-

-

116

- available-for-sale investments

-

-

-

-

152

-

-

152

- income tax

-

-

-

-

(36)

-

-

(36)

Total comprehensive income for the year

-

-

-

6,527

116

-

-

6,643

Shares issued under employee share plans

60

917

-

(53)

-

-

-

924

Shares issued in lieu of dividends and amounts arising thereon

134

(134)

-

2,709

-

-

-

2,709

Capital securities issued

-

-

5,648

-

-

-

-

5,648

Dividends to shareholders

-

-

-

(9,893)

-

-

-

(9,893)

Tax credit on distributions

-

-

-

104

-

-

-

104

Own shares adjustment

-

-

-

103

-

-

-

103

Exercise and lapse of share options

-

-

-

(37)

-

37

-

-

Cost of share-based payment arrangements

-

-

-

74

-

-

-

74

Income taxes on share-based payments

-

-

-

(2)

-

-

-

(2)

Equity investments granted to employees of subsidiaries under employee share plans

-

-

-

48

-

-

-

48

At 31 December 2014

9,609

11,918

11,476

34,986

240

2,089

35,127

105,445

Dividends per ordinary share at 31 December 2015 were $0.50 (2014: $0.49; 2013: $0.48).

The accompanying notes on pages 347 to 469 form an integral part of these financial statements1.

For footnotes, see page 346.

 

Footnotes to the Financial Statements

1 The audited sections of 'Risk' on pages 101 to 226, the audited sections of 'Capital' on pages 227 to 248 and the audited sections of 'Directors' Remuneration Report' on pages 285 to 321 are also an integral part of these financial statements.

2 During 2015, HSBC Holdings issued $2,450m and €1,000 of Perpetual Subordinated Contingent Convertible Capital Securities, on which there were $12m of external issuance costs, $25m of intra-group issuance costs and $19m of tax. In 2014, HSBC Holdings issued $2,250m, $1,500m and €1,500m of Perpetual Subordinated Contingent Convertible Capital Securities, on which there were $13m of external issuance costs and $33m of intra-group issuance costs.Under IFRSs these issuance costs and tax benefits are classified as equity.

3 Adjustment to bring changes between opening and closing balance sheet amounts to average rates. This is not done on a line-by-line basis, as details cannot be determined without unreasonable expense. 

4 Retained earnings include 81,580,180 ($1,604m) of own shares held within HSBC's Insurance business, retirement funds for the benefit of policyholders or beneficiaries within employee trusts for the settlement of shares expected to be delivered under employee share schemes or bonus plans, and the market-making activities in Markets (2014: 85,337,430 ($641m); 2013: 85,997,271 ($915m)).

5 At 31 December 2015, our operations in Brazil were classified as held for sale (see Note 23). The cumulative amount of other reserves attributable to these operations were as follows: available-for-sale fair value reserve debit of $176m, cash flow hedging reserve credit of $34m and foreign exchange reserve debit of $2.6bn.

6 Cumulative goodwill amounting to $5,138m has been charged against reserves in respect of acquisitions of subsidiaries prior to 1 January 1998, including $3,469m charged against the merger reserve arising on the acquisition of HSBC Bank plc. The balance of $1,669m has been charged against retained earnings.

7 Statutory share premium relief under Section 131 of the Companies Act 1985 (the 'Act') was taken in respect of the acquisition of HSBC Bank plc in 1992, HSBC France in 2000 and HSBC Finance Corporation in 2003 and the shares issued were recorded at their nominal value only. In HSBC's consolidated financial statements the fair value differences of $8,290m in respect of HSBC France and $12,768m in respect of HSBC Finance Corporation were recognised in the merger reserve. The merger reserve created on the acquisition of HSBC Finance Corporation subsequently became attached to HSBC Overseas Holdings (UK) Limited ('HOHU'), following a number of intra-group reorganisations. During 2009, pursuant to Section 131 of the Companies Act 1985, statutory share premium relief was taken in respect of the rights issue and $15,796m was recognised in the merger reserve. The merger reserve includes the deduction of $614m in respect of costs relating to the rights issue, of which $149m was subsequently transferred to the income statement. Of this $149m, $121m was a loss arising from accounting for the agreement with the underwriters as a contingent forward contract. The merger reserve excludes the loss of $344m on a forward foreign exchange contract associated with hedging the proceeds of the rights issue.

8 Retained earnings include 67,881 ($1m) (2014: 179,419 ($3m)) of own shares held to fund employee share plans.

9 Other paid-in capital arises from the exercise and lapse of share options granted to employees of HSBC Holdings subsidiaries.

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
ACSUWVVRNAAOAAR
Date   Source Headline
18th Jun 20245:32 pmRNSTransaction in Own Shares
17th Jun 20245:39 pmRNSTransaction in Own Shares
14th Jun 20245:20 pmRNSTransaction in Own Shares
14th Jun 202411:00 amRNSIssuance of contingent convertible securities
13th Jun 20245:30 pmRNSTransaction in Own Shares
13th Jun 20247:00 amRNSIssuance of contingent convertible securities
12th Jun 20245:24 pmRNSTransaction in Own Shares
11th Jun 20245:38 pmRNSTransaction in Own Shares
11th Jun 20241:00 pmRNSFirst Interim and Special Dividend - Exchange Rate
10th Jun 20245:15 pmRNSTransaction in Own Shares
7th Jun 20245:32 pmRNSTransaction in Own Shares
6th Jun 20245:16 pmRNSTransaction in Own Shares
5th Jun 20245:44 pmRNSTransaction in Own Shares
4th Jun 20245:22 pmRNSTransaction in Own Shares
3rd Jun 20245:12 pmRNSTransaction in Own Shares
31st May 20245:23 pmRNSTransaction in Own Shares
31st May 20244:30 pmRNSTotal Voting Rights
30th May 20245:28 pmRNSTransaction in Own Shares
29th May 20245:28 pmRNSTransaction in Own Shares
29th May 20244:30 pmRNSDirector/PDMR Shareholding
28th May 20245:27 pmRNSTransaction in Own Shares
28th May 20247:00 amRNSTransaction in Own Shares
24th May 20245:38 pmRNSTransaction in Own Shares
23rd May 20245:30 pmRNSTransaction in Own Shares
22nd May 20245:23 pmRNSTransaction in Own Shares
21st May 20245:25 pmRNSTransaction in Own Shares
20th May 20245:34 pmRNSTransaction in Own Shares
20th May 20243:06 pmRNSIssuance of senior unsecured notes
17th May 20245:32 pmRNSTransaction in Own Shares
17th May 20242:30 pmRNSIssuance of senior unsecured notes
16th May 20245:23 pmRNSTransaction in Own Shares
15th May 20245:40 pmRNSTransaction in Own Shares
15th May 202411:00 amRNSResults of tender offers for four series of notes
14th May 20245:55 pmRNSPricing terms for tender offers for notes
14th May 20245:54 pmRNSTransaction in Own Shares
14th May 20248:52 amRNSHolding(s) in Company
13th May 20245:30 pmRNSTransaction in Own Shares
13th May 20249:23 amRNSHolding(s) in Company
13th May 20249:16 amRNSPre Stabilisation Notice
10th May 20245:28 pmRNSTransaction in Own Shares
10th May 202410:01 amRNSDirector/PDMR Shareholding
10th May 202410:00 amRNSOverseas Regulatory Announcement - Grant of Awards
10th May 20249:03 amRNSHolding(s) in Company
9th May 20245:36 pmRNSTransaction in Own Shares
8th May 20245:40 pmRNSTransaction in Own Shares
8th May 20247:00 amRNSHSBC tender offers for four series of notes
7th May 202410:30 amRNSHSBC Holdings plc – Share buy-back
3rd May 20243:20 pmRNSAGM poll results + changes Board+Ctte composition
3rd May 202411:06 amRNSHSBC Holdings plc - AGM Statements
1st May 20244:30 pmRNSDirector Declaration

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.